2008
DOI: 10.1002/14651858.cd006163.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Parenteral calcium for intensive care unit patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
45
0
3

Year Published

2009
2009
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(49 citation statements)
references
References 57 publications
1
45
0
3
Order By: Relevance
“…A recent publication reviewed the topic of administering calcium for hypocalcemia in critically ill patients and concluded that there was a lack of evidence that parenteral calcium supplementation impacts the outcome of critically ill patients (18 ).…”
Section: Recently Published Reviewmentioning
confidence: 99%
“…A recent publication reviewed the topic of administering calcium for hypocalcemia in critically ill patients and concluded that there was a lack of evidence that parenteral calcium supplementation impacts the outcome of critically ill patients (18 ).…”
Section: Recently Published Reviewmentioning
confidence: 99%
“…Indeed, this controversial topic was highlighted in a prior Cochrane systematic review examining the effects of calcium supplementation in intensive care unit (ICU) patients. 1 Additional concerns related to iCa monitoring are the increased cost and laboratory resource utilization compared with total calcium monitoring. 2,3 In the absence of evidence to support routine iCa monitoring, we sought to characterize clinicians' ordering practices among several hospital internal medicine (HIM) services in a large academic medical center.…”
Section: Introductionmentioning
confidence: 99%
“…Although hypocalcemia is common in septic and critically ill patients, it may result from a shift of calcium to the intracellular compartment and indicate disease severity without directly contributing to patient outcome (7 ). Furthermore, in critically ill patients with iCa values over 4.0 mg/dL (1.0 mmol/L), supplementation has not been shown to improve outcome (8 ). Repeat testing of iCa therefore may lead to more unnecessary supplementation, which leads to more repeat testing.…”
mentioning
confidence: 99%